Clinitech Laboratory Ltd

Clinitech Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Clinitech Laboratory Ltd

₹ 79.0 13.18%
21 Nov - close price
Company website BSE - SME: 544220
About

Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.[1]

Key Points

Business Profile[1] The company performs over 150 tests in its centers, categorized into Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests, and Histopathology Tests.

Website BSE
  • Market Cap ₹ 18.0 Cr.
  • Current Price ₹ 79.0
  • High / Low ₹ 121 / 63.0
  • Stock P/E 50.1
  • Book Value ₹ 41.8
  • Dividend Yield 0.00 %
  • ROCE 14.8 %
  • ROE 12.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE SME IPO

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 Sep 2024
3.06 4.08
2.78 3.52
Operating Profit 0.28 0.56
OPM % 9.15% 13.73%
0.02 0.05
Interest 0.04 0.04
Depreciation 0.19 0.31
Profit before tax 0.07 0.26
Tax % 14.29% 15.38%
0.07 0.22
EPS in Rs 0.47 0.96
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
4.55 6.38 6.35 6.40
3.72 5.31 4.99 5.41
Operating Profit 0.83 1.07 1.36 0.99
OPM % 18.24% 16.77% 21.42% 15.47%
0.04 0.07 0.02 0.04
Interest 0.08 0.06 0.07 0.09
Depreciation 0.25 0.38 0.45 0.44
Profit before tax 0.54 0.70 0.86 0.50
Tax % 25.93% 27.14% 29.07% 26.00%
0.40 0.51 0.61 0.37
EPS in Rs 6.00 3.40 4.07 2.20
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 12%
TTM: 1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -1%
TTM: -41%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 22%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.67 1.50 1.50 1.68 2.28
Reserves 0.72 0.35 0.88 1.87 7.27
0.54 0.89 1.03 0.87 0.01
0.80 0.94 2.62 1.19 1.48
Total Liabilities 2.73 3.68 6.03 5.61 11.04
0.84 1.65 1.33 1.71 1.77
CWIP 0.08 0.41 0.56 0.94 1.00
Investments 0.09 0.14 2.02 0.07 0.07
1.72 1.48 2.12 2.89 8.20
Total Assets 2.73 3.68 6.03 5.61 11.04

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.38 0.96 1.25 0.11
0.54 -1.47 -0.65 -0.64
-0.88 0.29 0.09 0.45
Net Cash Flow 0.04 -0.22 0.68 -0.08

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 44.92 20.60 28.17 34.22
Inventory Days 32.21 40.28 43.68 92.91
Days Payable 164.61 130.90 124.79 116.14
Cash Conversion Cycle -87.48 -70.03 -52.95 10.99
Working Capital Days 48.13 25.74 9.77 57.60
ROCE % 32.55% 30.24% 14.81%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2024
61.58%
0.32%
38.11%
No. of Shareholders 346

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.